A transgenic mouse model in which the human IL-1β gene is overexpressed in the esophagus reflects the pathology underlying the progression toward Barrett’s esophagitis in humans, i.e., from low-grade and high-grade dysplasia to esophageal adenocarcinoma [15]. Here, IL1B is linked to esophageal adenocarcinoma.